Sanford C. Bernstein Initiates Coverage on agilon health (NYSE:AGL)

Sanford C. Bernstein started coverage on shares of agilon health (NYSE:AGL - Free Report) in a research report sent to investors on Wednesday morning, MarketBeat.com reports. The brokerage issued a market perform rating and a $2.50 price objective on the stock.

Several other brokerages have also issued reports on AGL. Evercore ISI cut their price target on agilon health from $7.00 to $4.00 and set an "in-line" rating on the stock in a report on Tuesday, October 8th. William Blair downgraded shares of agilon health from an "outperform" rating to a "market perform" rating in a research report on Friday, November 8th. Bank of America downgraded shares of agilon health from a "buy" rating to an "underperform" rating and set a $3.00 price objective on the stock. in a report on Wednesday, October 2nd. Citigroup reduced their price objective on shares of agilon health from $2.50 to $1.75 and set a "sell" rating for the company in a report on Wednesday, November 13th. Finally, Barclays dropped their price target on shares of agilon health from $5.00 to $2.00 and set an "underweight" rating on the stock in a research report on Monday, November 11th. Three analysts have rated the stock with a sell rating, sixteen have given a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, agilon health has a consensus rating of "Hold" and a consensus target price of $5.02.

agilon health Trading Down 5.2 %

AGL stock traded down $0.11 during midday trading on Wednesday, hitting $1.99. The stock had a trading volume of 3,303,303 shares, compared to its average volume of 4,867,141. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. The firm has a market cap of $819.92 million, a P/E ratio of -2.23 and a beta of 0.51. The business has a fifty day moving average price of $2.51 and a two-hundred day moving average price of $4.46. agilon health has a 1-year low of $1.50 and a 1-year high of $13.76.

agilon health (NYSE:AGL - Get Free Report) last announced its earnings results on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.19). The business had revenue of $1.45 billion for the quarter, compared to the consensus estimate of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. During the same quarter in the previous year, the company earned ($0.06) EPS. On average, sell-side analysts predict that agilon health will post -0.5 earnings per share for the current fiscal year.

Insider Buying and Selling at agilon health

In other news, CEO Steven Sell bought 20,000 shares of the stock in a transaction on Thursday, September 12th. The shares were acquired at an average cost of $3.36 per share, for a total transaction of $67,200.00. Following the purchase, the chief executive officer now directly owns 67,590 shares of the company's stock, valued at $227,102.40. This trade represents a 42.03 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 3.20% of the company's stock.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in AGL. J.Safra Asset Management Corp lifted its position in agilon health by 626.1% during the second quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company's stock valued at $27,000 after purchasing an additional 3,625 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new position in agilon health in the third quarter worth $28,000. CWM LLC increased its stake in agilon health by 406.5% in the second quarter. CWM LLC now owns 9,081 shares of the company's stock valued at $59,000 after acquiring an additional 7,288 shares during the last quarter. Nisa Investment Advisors LLC purchased a new stake in agilon health during the second quarter valued at about $60,000. Finally, Allspring Global Investments Holdings LLC lifted its stake in agilon health by 17,790.0% during the second quarter. Allspring Global Investments Holdings LLC now owns 10,734 shares of the company's stock worth $70,000 after purchasing an additional 10,674 shares during the last quarter.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.